This is a Validated Antibody Database (VAD) review about rat Flt1, based on 3 published articles (read how Labome selects the articles), using Flt1 antibody in all methods. It is aimed to help Labome visitors find the most suited Flt1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Flt1 synonym: FLT-1; VEGFR-1; vascular endothelial growth factor receptor 1; FMS-like tyrosine kinase 1; Fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor); tyrosine-protein kinase receptor FLT; vascular endothelial growth factor receptor 1-like; vascular endothelial growth factor/vascular permeability factor receptor
Invitrogen
| rabbit polyclonal |
| In order to find that that vascular endothelial growth factor 165b prevents activation of vascular endothelial growth factor receptor 1-STAT3 signaling by vascular endothelial growth factor 165a, Invitrogen Flt1 antibody (ThermoFisher, PA5-16493) was used in immunoprecipitation on mouse samples (fig 3b), in western blot on mouse samples (fig 3b), in immunoprecipitation on human samples (fig 5e) and in western blot on human samples (fig 5e). Circ Res (2017) ncbi |
| rabbit polyclonal |
| In order to isolate and characterize PDGFR-beta(+) perivascular cells from infantile hemangioma, Invitrogen Flt1 antibody (Thermo Scientific, RB-1527) was used in immunocytochemistry on human samples . Int J Clin Exp Pathol (2014) ncbi |
| rabbit polyclonal |
| In order to test if MSCs in hemangioma also reside in the perivascular region, Invitrogen Flt1 antibody (Thermo Scientific, RB-1527) was used in immunocytochemistry on human samples . Pediatr Dev Pathol (2012) ncbi |
Articles Reviewed
- Yuan S, Guo Y, Zhou X, Shen W, Chen H. PDGFR-? (+) perivascular cells from infantile hemangioma display the features of mesenchymal stem cells and show stronger adipogenic potential in vitro and in vivo. Int J Clin Exp Pathol. 2014;7:2861-70 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments
